Peritoneal Recurrence of Cecal Cancer with Specific Imaging Findings and Shrinkage after Treatment with Pembrolizumab

Pembrolizumab is one of the treatment options for treatment-refractory unresectable advanced or metastatic colorectal cancer with microsatellite instability-high (MSI-H) or deficiencies in DNA mismatch repair (dMMR). Herein, we report a case in which a recurrent cecal cancer lesion showed specific i...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Tomohiro, Shonaka, Tatsuya, Shimazaki, Ryotaro, Adachi, Yuki, Otani, Masahide, Matsushita, Wakako, Tani, Chikayoshi, Hasegawa, Kimiharu, Sumi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Society of Coloproctology 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801249/
https://www.ncbi.nlm.nih.gov/pubmed/35128139
http://dx.doi.org/10.23922/jarc.2021-053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801249/
https://www.ncbi.nlm.nih.gov/pubmed/35128139
http://dx.doi.org/10.23922/jarc.2021-053

Ejemplares similares